Where Does the Electron Transport Chain Occur in Mitochondria?

The electron transport chain (ETC) is a vital sequence of protein complexes and organic molecules that perform a crucial role in cellular energy production. This intricate system is responsible for generating the majority of the ATP (adenosine triphosphate), the cell’s energy currency, through a process called oxidative phosphorylation. But where exactly does this critical process take place within the cell? The answer lies within the mitochondria, often referred to as the “powerhouses of the cell.” Specifically, the electron transport chain is located in the inner mitochondrial membrane.

To understand why this location is so important, let’s delve into the fundamentals of cellular respiration and the role of the ETC within it.

Understanding the Basics of Cellular Respiration and Oxidative Phosphorylation

Aerobic cellular respiration, the process by which cells convert nutrients into usable energy, is composed of three main stages:

1. Glycolysis: This initial stage occurs in the cytoplasm and breaks down glucose into pyruvate, producing a small amount of ATP and NADH (nicotinamide adenine dinucleotide).
2. Citric Acid Cycle (Krebs Cycle): Taking place in the mitochondrial matrix, this cycle further oxidizes pyruvate (after its conversion to acetyl CoA) to produce carbon dioxide, ATP, NADH, and FADH2 (flavin adenine dinucleotide).
3. Oxidative Phosphorylation: This final and most significant stage, where the electron transport chain plays a central part, happens in the inner mitochondrial membrane. It utilizes the NADH and FADH2 generated in the previous stages to produce a substantial amount of ATP.

Oxidative phosphorylation itself is a two-part process:

• Electron Transport Chain (ETC): A series of protein complexes embedded in the inner mitochondrial membrane facilitate a sequence of redox reactions. Electrons are passed from one complex to the next, releasing energy as they move down the chain.
• Chemiosmosis: The energy released by the ETC is used to pump protons (H+) from the mitochondrial matrix into the intermembrane space, creating an electrochemical gradient. This gradient then drives ATP synthesis as protons flow back into the matrix through ATP synthase.

Photosynthesis, the process used by plants and some bacteria to convert light energy into chemical energy, also utilizes an electron transport chain. In this case, it’s located in the thylakoid membranes of chloroplasts. While the context differs, the fundamental principles of electron transport and energy conversion remain similar.

The Electron Transport Chain at the Cellular Level: Location and Function

The electron transport chain is not simply floating freely within the mitochondria. It is precisely organized within the inner mitochondrial membrane. This membrane is characterized by numerous folds called cristae, which significantly increase the surface area available for the ETC and oxidative phosphorylation to occur.

The ETC consists of several protein complexes, primarily labeled as Complex I, Complex II, Complex III, and Complex IV, along with mobile electron carriers like coenzyme Q (ubiquinone) and cytochrome c. These components are strategically positioned within the inner mitochondrial membrane to facilitate the ordered flow of electrons and the pumping of protons.

Here’s a simplified breakdown of the ETC process and the role of each complex within the inner mitochondrial membrane:

1. Complex I (NADH dehydrogenase): This complex, situated in the inner mitochondrial membrane, accepts electrons from NADH, which is produced in the citric acid cycle and glycolysis. As electrons move through Complex I, protons are pumped from the matrix to the intermembrane space.

2. Complex II (Succinate dehydrogenase): Also located in the inner mitochondrial membrane, Complex II receives electrons from FADH2, another electron carrier produced in the citric acid cycle. Electrons pass through Complex II to coenzyme Q, but unlike Complex I, Complex II does not directly pump protons.

   • Succinate + FAD -> Fumarate + 2 H+(matrix) + FADH2
   • FADH2 + CoQ -> FAD + CoQH2

3. Coenzyme Q (Ubiquinone): This mobile electron carrier, found within the inner mitochondrial membrane, accepts electrons from both Complex I and Complex II and transports them to Complex III.

4. Complex III (Cytochrome bc1 complex): Positioned in the inner mitochondrial membrane, Complex III receives electrons from coenzyme Q and passes them to cytochrome c. This complex is also a proton pump, contributing to the proton gradient. The Q cycle, a crucial part of Complex III’s function, further elaborates the transfer of electrons and proton pumping.

5. Cytochrome c: Another mobile electron carrier, cytochrome c is located in the intermembrane space and shuttles electrons from Complex III to Complex IV.

6. Complex IV (Cytochrome c oxidase): The final protein complex in the ETC, situated in the inner mitochondrial membrane, receives electrons from cytochrome c. Complex IV then transfers these electrons to the final electron acceptor, oxygen (O2), which is reduced to water (H2O). This complex is also a proton pump, contributing to the electrochemical gradient.

7. ATP Synthase (Complex V): While not directly part of the electron transport chain in terms of electron flow, ATP synthase is inextricably linked to it. This complex is also embedded in the inner mitochondrial membrane and harnesses the proton gradient generated by Complexes I, III, and IV. As protons flow back into the mitochondrial matrix through ATP synthase, the energy is used to convert ADP (adenosine diphosphate) and inorganic phosphate (Pi) into ATP. For approximately every 4 protons that pass through ATP synthase, one molecule of ATP is produced.

   • ATP synthase can also operate in reverse under certain conditions, consuming ATP to pump protons against their gradient, a process observed in some bacteria.

Molecular Players in the Electron Transport Chain

Key molecules like NADH and FADH2 are crucial for fueling the electron transport chain.

• NADH (Nicotinamide Adenine Dinucleotide): This molecule exists in two forms: NAD+ (oxidized) and NADH (reduced). NADH is a dinucleotide that carries high-energy electrons. It delivers electrons to Complex I of the ETC. For every NADH molecule oxidized, approximately 2.5 ATP molecules can be produced.

  • Reaction 1: RH2 + NAD+ -> R + H+ + NADH
  • Reaction 2: NADH -> H+ + NAD+ + 2 e- + H+

• FADH2 (Flavin Adenine Dinucleotide): Similar to NADH, FADH2 is an electron carrier. It delivers electrons to Complex II of the ETC. Oxidation of one FADH2 molecule can lead to the production of about 1.5 ATP molecules.

  • Reaction 3: FADH2 -> FAD + 2 H+ + 2 e-

FAD is also involved in various metabolic pathways outside the ETC, such as DNA repair and fatty acid oxidation.

Clinical Significance: Disruptions of the Electron Transport Chain

The proper functioning of the electron transport chain within the inner mitochondrial membrane is essential for cellular health. Disruptions to this process can have significant clinical consequences.

Uncoupling Agents: These substances disrupt the link between the ETC and ATP synthesis. They compromise the integrity of the inner mitochondrial membrane, making it permeable to protons. This proton leak diminishes the proton gradient, and while the ETC continues to function (and may even become overactive), ATP production is reduced or halted. The energy released by the ETC is then dissipated as heat, potentially leading to hyperthermia and metabolic disturbances like lactic acidosis. Examples include aspirin (salicylic acid) and thermogenin, a protein naturally found in brown adipose tissue that promotes heat generation.

Oxidative Phosphorylation Inhibitors: Certain toxins and drugs can directly inhibit specific complexes of the electron transport chain or ATP synthase. These inhibitors block electron flow, proton pumping, or ATP synthesis, leading to cellular energy deprivation. Examples include:

• Rotenone: Inhibits Complex I.
• Carboxin: Inhibits Complex II.
• Antimycin A: Inhibits Complex III.
• Cyanide and Carbon Monoxide (CO): Inhibit Complex IV. Cyanide poisoning, for instance, can result in tissue hypoxia unresponsive to oxygen supplementation and is associated with an almond breath odor. Treatment strategies for cyanide poisoning include nitrites and hydroxocobalamin.
• Oligomycin: Inhibits ATP synthase (Complex V).

Conclusion: The Inner Mitochondrial Membrane – The Stage for Cellular Energy Production

In summary, the electron transport chain is strategically located within the inner mitochondrial membrane. This location is crucial for its function, allowing for the creation of a proton gradient across the membrane that drives ATP synthesis. The intricate arrangement of protein complexes and mobile carriers within this membrane ensures the efficient transfer of electrons and the conversion of energy from nutrient molecules into the readily usable form of ATP. Understanding the precise location and function of the ETC within mitochondria is fundamental to comprehending cellular energy metabolism and its implications for health and disease.

References

1.Lencina AM, Franza T, Sullivan MJ, Ulett GC, Ipe DS, Gaudu P, Gennis RB, Schurig-Briccio LA. Type 2 NADH Dehydrogenase Is the Only Point of Entry for Electrons into the Streptococcus agalactiae Respiratory Chain and Is a Potential Drug Target. mBio. 2018 Jul 03;9(4) [PMC free article: PMC6030563] [PubMed: 29970468]

2.Hirst J. Towards the molecular mechanism of respiratory complex I. Biochem J. 2009 Dec 23;425(2):327-39. [PubMed: 20025615]

3.Sazanov LA, Hinchliffe P. Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus. Science. 2006 Mar 10;311(5766):1430-6. [PubMed: 16469879]

4.Hirst J. Energy transduction by respiratory complex I–an evaluation of current knowledge. Biochem Soc Trans. 2005 Jun;33(Pt 3):525-9. [PubMed: 15916556]

5.Yankovskaya V, Horsefield R, Törnroth S, Luna-Chavez C, Miyoshi H, Léger C, Byrne B, Cecchini G, Iwata S. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science. 2003 Jan 31;299(5607):700-4. [PubMed: 12560550]

6.Horsefield R, Iwata S, Byrne B. Complex II from a structural perspective. Curr Protein Pept Sci. 2004 Apr;5(2):107-18. [PubMed: 15078221]

7.Geertman JM, van Maris AJ, van Dijken JP, Pronk JT. Physiological and genetic engineering of cytosolic redox metabolism in Saccharomyces cerevisiae for improved glycerol production. Metab Eng. 2006 Nov;8(6):532-42. [PubMed: 16891140]

8.Thorpe C, Kim JJ. Structure and mechanism of action of the acyl-CoA dehydrogenases. FASEB J. 1995 Jun;9(9):718-25. [PubMed: 7601336]

9.Sun C, Benlekbir S, Venkatakrishnan P, Wang Y, Hong S, Hosler J, Tajkhorshid E, Rubinstein JL, Gennis RB. Structure of the alternative complex III in a supercomplex with cytochrome oxidase. Nature. 2018 May;557(7703):123-126. [PMC free article: PMC6004266] [PubMed: 29695868]

10.Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B, Link TA, Ramaswamy S, Jap BK. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science. 1998 Jul 03;281(5373):64-71. [PubMed: 9651245]

11.Trumpower BL. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. J Biol Chem. 1990 Jul 15;265(20):11409-12. [PubMed: 2164001]

12.Hunte C, Palsdottir H, Trumpower BL. Protonmotive pathways and mechanisms in the cytochrome bc1 complex. FEBS Lett. 2003 Jun 12;545(1):39-46. [PubMed: 12788490]

13.Calhoun MW, Thomas JW, Gennis RB. The cytochrome oxidase superfamily of redox-driven proton pumps. Trends Biochem Sci. 1994 Aug;19(8):325-30. [PubMed: 7940677]

14.Schmidt-Rohr K. Oxygen Is the High-Energy Molecule Powering Complex Multicellular Life: Fundamental Corrections to Traditional Bioenergetics. ACS Omega. 2020 Feb 11;5(5):2221-2233. [PMC free article: PMC7016920] [PubMed: 32064383]

15.Lovero D, Giordano L, Marsano RM, Sanchez-Martinez A, Boukhatmi H, Drechsler M, Oliva M, Whitworth AJ, Porcelli D, Caggese C. Characterization of Drosophila ATPsynC mutants as a new model of mitochondrial ATP synthase disorders. PLoS One. 2018;13(8):e0201811. [PMC free article: PMC6086398] [PubMed: 30096161]

16.Okuno D, Iino R, Noji H. Rotation and structure of FoF1-ATP synthase. J Biochem. 2011 Jun;149(6):655-64. [PubMed: 21524994]

17.Junge W, Nelson N. ATP synthase. Annu Rev Biochem. 2015;84:631-57. [PubMed: 25839341]

18.Hinkle PC. P/O ratios of mitochondrial oxidative phosphorylation. Biochim Biophys Acta. 2005 Jan 07;1706(1-2):1-11. [PubMed: 15620362]

19.Barrett MA, Zheng S, Roshankar G, Alsop RJ, Belanger RK, Huynh C, Kučerka N, Rheinstädter MC. Interaction of aspirin (acetylsalicylic acid) with lipid membranes. PLoS One. 2012;7(4):e34357. [PMC free article: PMC3328472] [PubMed: 22529913]

20.Warrick BJ, King A, Smolinske S, Thomas R, Aaron C. A 29-year analysis of acute peak salicylate concentrations in fatalities reported to United States poison centers. Clin Toxicol (Phila). 2018 Sep;56(9):846-851. [PubMed: 29431532]

21.Cinti S. The adipose organ. Prostaglandins Leukot Essent Fatty Acids. 2005 Jul;73(1):9-15. [PubMed: 15936182]

22.Enerbäck S. The origins of brown adipose tissue. N Engl J Med. 2009 May 07;360(19):2021-3. [PubMed: 19420373]

23.Zhou W, Faraldo-Gómez JD. Membrane plasticity facilitates recognition of the inhibitor oligomycin by the mitochondrial ATP synthase rotor. Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):789-796. [PMC free article: PMC6176861] [PubMed: 29630891]

24.Kamalian L, Douglas O, Jolly CE, Snoeys J, Simic D, Monshouwer M, Williams DP, Kevin Park B, Chadwick AE. The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity. Toxicol In Vitro. 2018 Dec;53:136-147. [PubMed: 30096366]

25.Wood DM, Alsahaf H, Streete P, Dargan PI, Jones AL. Fatality after deliberate ingestion of the pesticide rotenone: a case report. Crit Care. 2005 Jun;9(3):R280-4. [PMC free article: PMC1175899] [PubMed: 15987402]

26.Lupescu A, Jilani K, Zbidah M, Lang F. Induction of apoptotic erythrocyte death by rotenone. Toxicology. 2012 Oct 28;300(3):132-7. [PubMed: 22727881]

27.Wallace KB. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol. 2003 Sep;93(3):105-15. [PubMed: 12969434]

28.Weaver LK. Clinical practice. Carbon monoxide poisoning. N Engl J Med. 2009 Mar 19;360(12):1217-25. [PubMed: 19297574]

29.Sato K, Tamaki K, Hattori H, Moore CM, Tsutsumi H, Okajima H, Katsumata Y. Determination of total hemoglobin in forensic blood samples with special reference to carboxyhemoglobin analysis. Forensic Sci Int. 1990 Nov;48(1):89-96. [PubMed: 2279722]

30.Barker SJ, Tremper KK. The effect of carbon monoxide inhalation on pulse oximetry and transcutaneous PO2. Anesthesiology. 1987 May;66(5):677-9. [PubMed: 3578881]

31.Raub JA, Mathieu-Nolf M, Hampson NB, Thom SR. Carbon monoxide poisoning–a public health perspective. Toxicology. 2000 Apr 07;145(1):1-14. [PubMed: 10771127]

32.Jensen P, Wilson MT, Aasa R, Malmström BG. Cyanide inhibition of cytochrome c oxidase. A rapid-freeze e.p.r. investigation. Biochem J. 1984 Dec 15;224(3):829-37. [PMC free article: PMC1144519] [PubMed: 6098268]

33.Shchepina LA, Pletjushkina OY, Avetisyan AV, Bakeeva LE, Fetisova EK, Izyumov DS, Saprunova VB, Vyssokikh MY, Chernyak BV, Skulachev VP. Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene. 2002 Nov 21;21(53):8149-57. [PubMed: 12444550]